Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer

International Journal of Urology

Volumn 11, Issue 8, 2004, Pages 613-618

  Kawakami, Satoru ^a   Kihara, Kazunori ^a   Fujii, Yasuhisa ^a   Masuda, Hitoshi ^a   Kobayashi, Tsuyoshi ^a   Kageyama, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Biopsy; Prostate specific antigen; Prostatic neoplasms; Stage T1c prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; APPARATUS; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERINEUM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; SAFETY; TRANSPERINEAL 14 CORE SYSTEMATIC PROSTATE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALPATION; PERINEUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; SURGERY, COMPUTER-ASSISTED;

EID: 4344718904     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00863.x     Document Type: Article

References (36)

1. Gretzwe MB, Partin AW. PSA levels and the probability of prostate cancer on biopsy. Eur. Urol. Suppl. 2002; 1: 21-7.
2. Smith RA, Cokkinides V, von Eschenbach AC et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J. Clin. 2002; 52: 8-22.
3. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001; 58: 842-8.
4. Holm HH, Gammelgaard J. Ultrasonically guided precise needle placement in the prostate and the seminal vesicles. J. Urol. 1981; 125: 385-7.
5. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J. Urol. 1989; 142: 71-4.
6. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50: 562-6.
7. Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR. Incidence and clinical significance of false-negative sextant prostate biopsies. J. Urol. 1998; 159: 1247-50.
8. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J. Urol. 1997; 157: 199-202.
9. Chang JJ, Shinohara K, Bhargava V, Presti JC. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J. Urol. 1998; 160: 2111-14.
10. Stamey TA. Making the most of six systematic sextant biopsies. Urology 1995; 45: 2-12.
11. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J. Urol. 2000; 164: 388-92.
12. Davis M, Sofer M, Kim SS, Soloway MS. The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J. Urol. 2002; 167: 566-70.
13. McNeal JE. Normal histology of the prostate. Am. J. Surg. Pathol. 1988; 12: 619-33.
14. Jack GS, Cookson MS, Coffey CS et al. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors. J. Urol. 2002; 168: 519-24.
15. Elgamal AA, Van Poppel HP, Van de Voorde WM, Van Dorpe JA, Oyen RH, Baert LV. Impalpable invisible stage T1c prostate cancer: Characteristics and clinical relevance in 100 radical prostatectomy specimens - a different view. J. Urol. 1997; 157: 244-50.
16. Stamey TA, Dietrick DD, Issa MM. Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen. J. Urol. 1993; 149: 510-15.
17. Presti JC, Chang JJ, Bhagrava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial. J. Urol. 2000; 163: 163-7.
18. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J. Urol. 2000; 164: 393-6.
19. Lerner SE, Seay TM, Blute ML, Bergstralh EJ, Barrett D, Zincke H. Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis. J. Urol. 1996; 155: 821-6.
20. International Union Against Cancer. Urologic tumors. Prostate. In: Sobin LH, Wittekind Ch (eds). TNM Classification of Malignant Tumours, 6th edn. John Wiley & Sons, New York 2002; 170-3.
21. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J. Urol. 1991; 145: 984-7.
22. Emiliozzi P, Longhi S, Scarpone P, Pansadoro A, DePaula F, Pansadoro V. The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen. J. Urol. 2001; 166: 845-50.
23. Kojima M, Hayakawa T, Saito T, Mitsuya H, Hayase Y. Transperineal 12-core systematic biopsy in the detection of prostate cancer. Int. J. Urol. 2001; 8: 301-7.
24. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schroder FH. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002; 60: 826-30.
25. Cooner WH, Mosley BR, Rutherford CL Jr et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J. Urol. 2002; 167: 966-73.
26. Igel TC, Knight MK, Young PR et al. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk. J. Urol. 2001; 165: 1575-9.
27. Naughton CK, Ornstein DK, Smith DS, Catalona WJ. Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J. Urol. 2000; 163: 168-71.
28. Peyromaure M, Ravery V, Messas A, Toublanc M, Boccon-Gibod L. Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients. J. Urol. 2002; 167: 218-21.
29. Webb JA, Shanmuganathan K, McLean A. Complications of ultrasound-guided transperineal prostate biopsy. A prospective study. Br. J. Urol. 1993; 72: 775-7.
30. Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J. Urol. 1998; 160: 2115-20.
31. Breslin JA, Turner BI, Faber RB, Rhamy RK. Anaerobic infection as a consequence of transrectal prostatic biopsy. J. Urol. 1978; 120: 502-3.
32. Brewster SF, Rooney N, Kabala J, Feneley RC. Fatal anaerobic infection following transrectal biopsy of a rare prostatic tumor. Br. J. Urol. 1993; 72: 977-8.
33. Stamey TA, Villers AA, McNeal JE, Link PC, Freiha FS. Positive surgical margins at radical prostatectomy: importance of the apical dissection. J. Urol. 1990; 143: 1166-72.
34. Ohori M, Abbas F, Wheeler TM, Kattan MW, Scardino PT, Lerner SP. Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. J. Urol. 1999; 161: 500-4.
35. Rogatsch H, Horninger W, Volgger H, Bartsch G, Mikuz G, Mairinger T. Radical prostatectomy: the value of preoperative, individually labelled apical biopsies. J. Urol. 2000; 164: 754-7.
36. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000; 89: 1800-9.